Meta-analysisindependent cross-checkabstract only checked★ key study I-ABX-04 in-depth review

Early antibiotics and childhood overweight (meta-analysis 2023)

Early-life exposure to antibiotics and excess body weight in childhood and adolescence: A systematic review and meta-analysis.

Overview

Chagas AP et al.. Obes Res Clin Pract 2023 · PMID 37573229 · DOI 10.1016/j.orcp.2023.07.001

A small association (about 9-10% higher odds) was found, but certainty was very low.

Does the study support the specific claim? Partly · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Pool cohort studies.

How was the study done?

Meta-analysis.

How many people, animals or samples were studied?

42 studies.

What was actually found?

Small association.

How large was the observed effect?

OR 1.09; 4+ courses 1.31.

What do the results mean in everyday life?

Possible small effect.

What are the study's limitations?

Very low certainty.

What does it say about Elawady's specific claim?

Weakly supports.

Do the results apply to Germany and Europe?

Moderate.

What can explicitly not be concluded from this study?

Causation.

Scientific in-depth review

1. Full reference

Authors
Chagas AP et al.
Journal
Obes Res Clin Pract
Year
2023
Identifier
PMID 37573229 DOI 10.1016/j.orcp.2023.07.001
Verification
verified – PubMed efetch 2026-10-25
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

Declaration of Competing Interest The authors of the manuscript entitled ‘Early-life exposure to antibiotics and excess body weight in childhood and adolescence: a systematic review and meta-analysis’ and whose names are listed immediately below certify that they have NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial intere

2. Research question

Early-life antibiotics and overweight/obesity

3. Study design and population

Study design
Meta-analysis – Systematic review and meta-analysis of cohort studies (PROSPERO-registered, GRADE)
Population

Children and adolescents

Country

Multinational

Period

to August 2022

Sample size

42 studies (28 pooled)

Inclusion and exclusion criteria

Cohort studies

4. Methods and endpoints

Exposure / intervention

Antenatal/postnatal antibiotics

Comparator

Unexposed

Endpoints

Overweight/obesity

Statistical methods

Random effects; GRADE

5. Actual results

Results

Antenatal OR 1.10 (1.04-1.16; very low certainty); postnatal OR 1.09 (1.05-1.12; very low certainty); 1 course OR 1.07 (1.00-1.15); >=4 courses OR 1.31 (1.17-1.46).

Absolute risks

not reported

Authors' conclusion

Association, but very low certainty; need studies addressing confounding.

6. Strengths

  • GRADE
  • Registered

7. Weaknesses

  • Observational primary studies

8. Risk of bias

Orienting tool
AMSTAR 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns

9. Assessment of the statistical interpretation

Small ORs.

10. Relevance to the specific claim

C-ABX-05 (mixed).

11. Independent contrary findings

12. Transferability to Germany and Europe

Moderate.

13. Overall methodological judgement

Certainty very low.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultshigh
Directnessdirect
Reproducibilityreplicated
Consistency with the overall evidenceconsistent
Regional transferabilitymoderate
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

15. Linked fact checks